Director of the UPMC Eye Center and Chair of Ophthalmology at the University of Pittsburgh Dr. José-Alain Sahel and collaborators reported the first-ever case of partial vision restoration in a blind patient after optogenetic therapy.
The pioneering study, published in Nature Medicine, describes the first time a patient has achieved partial functional recovery in any neurodegenerative disease by using optogenetic tools, assisted by the use of algal protein therapy. The breakthrough achievement is a culmination of 13 years of collaboration between the teams of Dr. Sahel in Pittsburgh and Paris and Dr. Botond Roska in Basel, Switzerland.
All rights reserved. Permission required to reprint articles in their entirety. Must include copyright statement and live hyperlinks. Contact email@example.com. Algae Planet accepts unsolicited manuscripts for consideration, and takes no responsibility for the validity of claims made in submitted editorial.